search
Back to results

A Safety and Effectiveness Study of a Contact Lens Cleaning and Disinfecting Solution

Primary Purpose

Refractive Ametropia

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
BL-3100-NBR03 multi-purpose solution
renu® Advanced Formula multi-purpose solution
Sponsored by
Bausch & Lomb Incorporated
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Refractive Ametropia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Is of legal age (at least 18) on the date the Informed Consent Form (ICF) is signed
  2. Is able to read, understand, and provide written informed consent on the Institutional Review Board (IRB)/Ethics Committee (EC) approved ICF and provide authorization as appropriate for local privacy regulations
  3. Is a habitual wearer (at least 3 months)
  4. Has typically cleaned and disinfected their pre-study contact lenses daily
  5. Has typically replaced their pre-study contact lenses monthly
  6. Must have spectacle correctable distance visual acuity through spherocylindrical refraction to 40 letters (0.14 logarithm of the minimal angle of resolution (logMAR) or better in each eye, at 2 meters distance with high contrast chart
  7. Has clear central corneas and is free of any anterior segment disorders
  8. Is a habitual user of a lens care product for cleaning, disinfecting, and storage of lenses
  9. Requires lens correction in both eyes
  10. Wears the same manufacturer and brand of lens in both eyes
  11. Agrees to wear study lenses on a daily wear basis for approximately three months
  12. Is willing and able to comply with all treatment and follow-up/study procedures.

Exclusion Criteria:

  1. Is currently using a hydrogen-peroxide cleaning and disinfecting solution
  2. Participated in any drug or device clinical investigation within 30 days prior to entry into this study
  3. Is a female of childbearing potential (those who are not surgically sterilized or postmenopausal) if they meet any one of the following conditions:

    • they are currently pregnant
    • they plan to become pregnant during the study
    • they are breastfeeding
  4. Has worn gas permeable (GP) lenses within the last 30 days
  5. Has worn polymethylmethacrylate (PMMA) lenses within the last three months
  6. Has typically worn their pre-study contact lenses on an extended wear basis, sleeping in their lenses one night or more per week, during the last year
  7. Has any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study
  8. Has any ocular disease, or is using any ocular medication.
  9. Is using any medications that will, in the Investigator's opinion, affect ocular physiology or lens performance
  10. Currently wears monovision, multifocal, or toric contact lenses
  11. Has ocular astigmatism of 1.00D or greater in either eye
  12. Has anisometropia (spherical equivalent) of greater than 2.00D
  13. Has any grade 2 or greater finding during the slit-lamp examination (refer to Appendix B for Methods of Clinical Evaluation)
  14. Has corneal infiltrates, of ANY GRADE
  15. Has any "Present" ungraded finding during the slit-lamp examination (refer to Appendix B for Methods of Clinical Evaluation) that, in the Investigator's judgment, interferes with contact lens wear
  16. Has any scar or neovascularization within the central 6 mm of the cornea, irregular cornea or a history of herpetic keratitis

    ◊ Note that subjects with minor peripheral corneal scarring (that does not extend into the 6 mm central area), that, in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.

  17. Is aphakic
  18. Is amblyopic
  19. Has had any corneal surgery (e.g., refractive surgery)
  20. Is allergic to any component in the study care products.
  21. Is an employee of any of the study investigative sites or a family member of an employee of the investigative site, including family members living outside of the employee's household
  22. Is an Ophthalmologist, an Optometrist, an Optician, or an Ophthalmic Assistant/Technician, or currently resides with a person with any of these specialties
  23. Is an employee of a manufacturer of contact lenses or contact lens care products (e.g., Alcon, Bausch + Lomb, Ciba Vision, CooperVision, Vistakon, Johnson & Johnson, etc.) or currently resides with a person employed by any of these manufacturers.

Sites / Locations

  • Eric White OD IncRecruiting
  • Lee & Woo OptometryRecruiting
  • Chester T Roe III MD Prof LLCRecruiting
  • Pearle VisionRecruiting
  • Golden VisionRecruiting
  • The Eyecare Studio, LLCRecruiting
  • Kannarr EyeCareRecruiting
  • Casco Bay EyeCareRecruiting
  • Koetting AssociatesRecruiting
  • Spectrum EyecareRecruiting
  • Saccco Eye GroupRecruiting
  • Oculus ResearchRecruiting
  • Total Eye Care, PARecruiting
  • Optometric Physicians of Middle TennesseeRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

BL-3100-NBR03

renu® Advanced Formula

Arm Description

BL-3100-NBR03 multi-purpose solution

renu® Advanced Formula multi-purpose solution

Outcomes

Primary Outcome Measures

Overall comfort averaged over all scheduled follow-up visits
Overall comfort will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response
Vision averaged over all scheduled follow-up visits
Vision will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response
The proportion of eyes with a maximum degree of front surface deposits grade of < 2 over all scheduled follow-up visits
The degree of front surface deposits will be graded for each eye as 0, 1, 2, 3, or 4.
The proportion of eyes with any slit-lamp findings greater than Grade 2 over all follow-up visits.
Graded slit-lamp findings will be assessed for each eye using Grades 0 through 4.

Secondary Outcome Measures

Full Information

First Posted
September 30, 2022
Last Updated
June 9, 2023
Sponsor
Bausch & Lomb Incorporated
search

1. Study Identification

Unique Protocol Identification Number
NCT05565937
Brief Title
A Safety and Effectiveness Study of a Contact Lens Cleaning and Disinfecting Solution
Official Title
A Safety and Effectiveness Study of a Contact Lens Cleaning and Disinfecting Solution
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 12, 2023 (Actual)
Primary Completion Date
August 30, 2023 (Anticipated)
Study Completion Date
August 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bausch & Lomb Incorporated

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Approximately 340 participants (680 eyes) will be enrolled in this three-month, two-arm, 1:1 randomized, parallel-group, bilateral, double-masked study at approximately 22 investigative sites in the United States. Participants will be required to wear dispensed study lenses on a daily wear basis for three months with scheduled in-office replacement of study lenses at the 1-Month and 2-Month Follow-Up Visits.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Refractive Ametropia

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
340 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
BL-3100-NBR03
Arm Type
Experimental
Arm Description
BL-3100-NBR03 multi-purpose solution
Arm Title
renu® Advanced Formula
Arm Type
Active Comparator
Arm Description
renu® Advanced Formula multi-purpose solution
Intervention Type
Device
Intervention Name(s)
BL-3100-NBR03 multi-purpose solution
Intervention Description
BL-3100-NBR03 multi-purpose solution used to clean and disinfect contact lenses
Intervention Type
Device
Intervention Name(s)
renu® Advanced Formula multi-purpose solution
Intervention Description
renu® Advanced Formula multi-purpose solution used to clean and disinfect contact lenses
Primary Outcome Measure Information:
Title
Overall comfort averaged over all scheduled follow-up visits
Description
Overall comfort will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response
Time Frame
3 months
Title
Vision averaged over all scheduled follow-up visits
Description
Vision will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response
Time Frame
3 months
Title
The proportion of eyes with a maximum degree of front surface deposits grade of < 2 over all scheduled follow-up visits
Description
The degree of front surface deposits will be graded for each eye as 0, 1, 2, 3, or 4.
Time Frame
3 months
Title
The proportion of eyes with any slit-lamp findings greater than Grade 2 over all follow-up visits.
Description
Graded slit-lamp findings will be assessed for each eye using Grades 0 through 4.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Is of legal age (at least 18) on the date the Informed Consent Form (ICF) is signed Is able to read, understand, and provide written informed consent on the Institutional Review Board (IRB)/Ethics Committee (EC) approved ICF and provide authorization as appropriate for local privacy regulations Is a habitual wearer (at least 3 months) Has typically cleaned and disinfected their pre-study contact lenses daily Must have spectacle correctable distance visual acuity through spherocylindrical refraction to 40 letters (0.14 logarithm of the minimal angle of resolution (logMAR) or better in each eye, at 2 meters distance with high contrast chart Has clear central corneas and is free of any anterior segment disorders Is a habitual user of a lens care product for cleaning, disinfecting, and storage of lenses Requires lens correction in both eyes Wears the same manufacturer and brand of lens in both eyes Agrees to wear study lenses on a daily wear basis for approximately three months Is willing and able to comply with all treatment and follow-up/study procedures. Exclusion Criteria: Is currently using a hydrogen-peroxide cleaning and disinfecting solution Participated in any drug or device clinical investigation within 30 days prior to entry into this study Is a female of childbearing potential (those who are not surgically sterilized or postmenopausal) if they meet any one of the following conditions: they are currently pregnant they plan to become pregnant during the study they are breastfeeding Has worn gas permeable (GP) lenses within the last 30 days Has worn polymethylmethacrylate (PMMA) lenses within the last three months Has typically worn their pre-study contact lenses on an extended wear basis, sleeping in their lenses one night or more per week, during the last year Has any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study Subjects with an active ocular disease, or who are using any ocular medication. Is using any medications that will, in the Investigator's opinion, affect ocular physiology or lens performance Currently wears monovision, multifocal, or toric contact lenses Has ocular astigmatism of 1.00D or greater in either eye Has anisometropia (spherical equivalent) of greater than 2.00D Has any grade 2 or greater finding during the slit-lamp examination (refer to Appendix B for Methods of Clinical Evaluation) Has corneal infiltrates, of ANY GRADE Has any "Present" ungraded finding during the slit-lamp examination (refer to Appendix B for Methods of Clinical Evaluation) that, in the Investigator's judgment, interferes with contact lens wear. Has typically worn their pr-study control lenses on an extended wear bases, sleeping on their lenses one night or more per week, during the last year. Is aphakic Is amblyopic Has had any corneal surgery (e.g., refractive surgery) Is allergic to any component in the study care products. Is an employee of any of the study investigative sites or a family member of an employee of the investigative site, including family members living outside of the employee's household Is an Ophthalmologist, an Optometrist, an Optician, or an Ophthalmic Assistant/Technician, or currently resides with a person with any of these specialties Is an employee of a manufacturer of contact lenses or contact lens care products (e.g., Alcon, Bausch + Lomb, Ciba Vision, CooperVision, Vistakon, Johnson & Johnson, etc.) or currently resides with a person employed by any of these manufacturers.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Daniel Donatello
Phone
5853385306
Email
Daniel.Donatello@bausch.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Donatello
Organizational Affiliation
Bausch & Lomb Incorporated
Official's Role
Study Director
Facility Information:
Facility Name
Eric White OD Inc
City
San Diego
State/Province
California
ZIP/Postal Code
92123
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eric White
Facility Name
Lee & Woo Optometry
City
San Francisco
State/Province
California
ZIP/Postal Code
94112
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kim Lee
Phone
415-269-3293
Email
drkimlee62@gmail.com
Facility Name
Chester T Roe III MD Prof LLC
City
Denver
State/Province
Colorado
ZIP/Postal Code
80246
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sherwyn Vicksman
Phone
720-218-1075
Email
svicksman@drcroe.com
Facility Name
Pearle Vision
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32246
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jon Walker
Phone
904-998-9871
Email
JonWalkerOD@Me.com
Facility Name
Golden Vision
City
Sarasota
State/Province
Florida
ZIP/Postal Code
34237
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wayne Golden
Phone
941-342-9711
Email
dr@goldenvisiononline.com
Facility Name
The Eyecare Studio, LLC
City
Decatur
State/Province
Georgia
ZIP/Postal Code
30035
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Keith Fishe
Phone
770-314-3756
Email
drfishe2@gmail.com
Facility Name
Kannarr EyeCare
City
Pittsburg
State/Province
Kansas
ZIP/Postal Code
66762
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shane Kannarr, OD
First Name & Middle Initial & Last Name & Degree
Chris Jacquinot, OD
Facility Name
Casco Bay EyeCare
City
Portland
State/Province
Maine
ZIP/Postal Code
04101
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steven Goldstein
Phone
207-773-2020
Email
sgoldstein@cascobayeye.com
Facility Name
Koetting Associates
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63144
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carmen Castellano, MD
First Name & Middle Initial & Last Name & Degree
Carmen Castellano
Facility Name
Spectrum Eyecare
City
Jamestown
State/Province
New York
ZIP/Postal Code
14701
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christopher Colburn
Phone
716-664-7601
Email
ccolburn@stny.rr.com
Facility Name
Saccco Eye Group
City
Vestal
State/Province
New York
ZIP/Postal Code
13850
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andrew Sacco
Phone
607-343-0782
Email
asacco@stny.rr.com
Facility Name
Oculus Research
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27603
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Erik Aune
Phone
919-346-6945
Email
info@oculusresearch@gmail.com
Facility Name
Total Eye Care, PA
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38119
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Caitlin Pearson
Phone
978-685-8900
Email
cpearson@oraclinical.com
Facility Name
Optometric Physicians of Middle Tennessee
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37205
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Richard Durocher
Phone
615-519-6242
Email
RD@OPMT.COM

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

A Safety and Effectiveness Study of a Contact Lens Cleaning and Disinfecting Solution

We'll reach out to this number within 24 hrs